Adherence and Subthreshold Adherence in Sleep Apnea Subjects Receiving Positive Airway Pressure Therapy: A Retrospective Study Evaluating Differences in Adherence Versus Use

References

1. 1.↵
   1. Schwab RJ,
   2. Badr SM,
   3. Epstein LJ,
   4. Gay PC,
   5. Gozal D,
   6. Kohler M,
   7. et al

   . An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems: the optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med 2013;188(5):613–620.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Kribbs NB,
   2. Pack AI,
   3. Kline LR,
   4. Smith PL,
   5. Schwartz AR,
   6. Schubert NM,
   7. et al

   . Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147(4):887–895.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Ayas N,
   2. Skomro R,
   3. Blackman A,
   4. Curren K,
   5. Fitzpatrick M,
   6. Fleetham J,
   7. et al

   . Obstructive sleep apnea and driving: a Canadian Thoracic Society and Canadian Sleep Society position paper. Can Respir J 2014;21(2):114–123.

   OpenUrlPubMed
4. 4.
   1. Kim JH,
   2. Kwon MS,
   3. Song HM,
   4. Lee BJ,
   5. Jang YJ,
   6. Chung YS

   . Compliance with positive airway pressure treatment for obstructive sleep apnea. Clin Exp Otorhinolaryngol 2009;2(2):90–96.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   European Sleep and Diagnostics Reimbursement Overview. ResMed, 2015. Correspondence from ResMed.
6. 6.↵
   1. Reeves-Hoche MK,
   2. Meck R,
   3. Zwillich CW

   . Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994;149(1):149–154.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.
   1. Salepci B,
   2. Caglayan B,
   3. Kiral N,
   4. Parmaksiz ET,
   5. Comert SS,
   6. Sarac G,
   7. et al

   . CPAP adherence of patients with obstructive sleep apnea. Respir Care 2013;58(9):1467–1473.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Weaver TE,
   2. Grunstein RR

   . Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008;5(2):173–178.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Sackett DL,
   2. Straus SE,
   3. Richardson WS,
   4. Rosenberg W,
   5. Haynes RB

   . Evidence-based medicine: how to practice and teach EBM. 2nd edition. Edinburgh, Scotland: Churchhill Livingstone; 2000:173–177.
10. 10.↵
    1. Billings ME,
    2. Kapur VK

    . Medicare long-term CPAP coverage policy: a cost-utility analysis. J Clin Sleep Med 2013;9(10):1023–1029.

    OpenUrlPubMed
11. 11.↵
    1. Wolkove N,
    2. Baltzan M,
    3. Kamel H,
    4. Dabrusin R,
    5. Palayew M

    . Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Can Respir J 2008;15(7):365–369.

    OpenUrlPubMed
12. 12.↵
    1. Anderson L

    . In search of compliance. http://www.homecaremag.com/hme-products/search-compliance Cahaba Media Group, Home Care 2012.
13. 13.↵
    1. Borel JC,
    2. Tamisier R,
    3. Dias-Domingos S,
    4. Sapene M,
    5. Martin F,
    6. Stach B,
    7. et al

    . Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS One 2013;8(5):e64382.

    OpenUrlPubMed
14. 14.
    1. Weaver TE,
    2. Kribbs NB,
    3. Pack AI,
    4. Kline LR,
    5. Chugh DK,
    6. Maislin G,
    7. et al

    . Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997;20(4):278–283.

    OpenUrlPubMedWeb of Science
15. 15.
    1. Wild MR,
    2. Engleman HM,
    3. Douglas NJ,
    4. Espie CA

    . Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J 2004;24(3):461–465.

    OpenUrlAbstract/FREE Full Text
16. 16.
    1. Broström A,
    2. Nilsen P,
    3. Johansson P,
    4. Ulander M,
    5. Strömberg A,
    6. Svanborg E,
    7. Fridlund B

    . Putative facilitators and barriers for adherence to CPAP treatment in patients with obstructive sleep apnea syndrome: a qualitative content analysis. Sleep Med 2010;11(2):126–130.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Bollig SM

    . Encouraging CPAP adherence: it is everyone's job. Respir Care 2010;55(9):1230–1239.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Kingshott RN,
    2. Vennelle M,
    3. Hoy CJ,
    4. Engleman HM,
    5. Deary IJ,
    6. Douglas NJ

    . Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med 2000;161(3 Pt 1):866–871.

    OpenUrlPubMedWeb of Science
19. 19.
    1. Stradling JR,
    2. Davies RJ

    . Is more NCPAP better? Sleep 2000;23(Suppl 4):S150–S153.

    OpenUrlPubMedWeb of Science
20. 20.
    1. Faccenda JF,
    2. Mackay TW,
    3. Boon NA,
    4. Douglas NJ

    . Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163(2):344–348.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.
    1. Weaver TE,
    2. Maislin G,
    3. Dinges DF,
    4. Bloxham T,
    5. George CF,
    6. Greenberg H,
    7. et al

    . Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30(6):711–719.

    OpenUrlPubMedWeb of Science
22. 22.↵
    1. Antic NA,
    2. Catcheside P,
    3. Buchan C,
    4. Hensley M,
    5. Naughton MT,
    6. Rowland S,
    7. et al

    . The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 2011;34(1):111–119.

    OpenUrlPubMedWeb of Science
23. 23.↵
    1. Engleman HM,
    2. Martin SE,
    3. Deary IJ,
    4. Douglas NJ

    . Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343(8897):572–575.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Martinez-Garcia MA,
    2. Soler-Cataluna JJ,
    3. Ejarque-Martinez L,
    4. Soriano Y,
    5. Roman-Sanchez P,
    6. Illa FB,
    7. et al

    . Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009;180(1):36–41.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. McDaid C,
    2. Griffin S,
    3. Weatherly H,
    4. Duree K,
    5. van der BM,
    6. van Hout S,
    7. et al

    . Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess 2009;13(4):iii–iv, xi–xiv, 1–119.

    OpenUrlCrossRef
26. 26.↵
    1. Peker Y,
    2. Hedner J,
    3. Johansson A,
    4. Bende M

    . Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. Sleep 1997;20(8):645–653.

    OpenUrlPubMedWeb of Science
27. 27.↵
    1. Stepnowsky CJ Jr.,
    2. Moore PJ

    . Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance. J Psychosom Res 2003;54(6):599–605.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Campos-Rodriguez F,
    2. Peña-Griñan N,
    3. Reyes-Nuñez N,
    4. De la Cruz-Moron I,
    5. Perez-Ronchel J,
    6. De la Vega-Gallardo F,
    7. Fernandez-Palacin A

    . Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005;128(2):624–633.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.
    1. Engleman HM,
    2. Cheshire KE,
    3. Deary IJ,
    4. Douglas NJ

    . Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax 1993;48(9):911–914.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Engleman HM,
    2. Kingshott RN,
    3. Wraith PK,
    4. Mackay TW,
    5. Deary IJ,
    6. Douglas NJ

    . Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159(2):461–467.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.
    1. Jenkinson C,
    2. Davies RJ,
    3. Mullins R,
    4. Stradling JR

    . Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353(9170):2100–2105.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.↵
    1. Redline S,
    2. Adams N,
    3. Strauss ME,
    4. Roebuck T,
    5. Winters M,
    6. Rosenberg C

    . Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998;157(3 Pt 1):858–865.

    OpenUrlPubMedWeb of Science
33. 33.↵
    1. Zimmerman ME,
    2. Arnedt JT,
    3. Stanchina M,
    4. Millman RP,
    5. Aloia MS

    . Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. Chest 2006;130(6):1772–1778.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Aloia MS,
    2. Knoepke CE,
    3. Lee-Chiong T

    . The new local coverage determination criteria for adherence to positive airway pressure treatment: testing the limits? Chest 2010;138(4):875–879.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Wickwire EM,
    2. Lettieri CJ,
    3. Cairns AA,
    4. Collop NA

    . Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest 2013;144(2):680–693.

    OpenUrlPubMed
36. 36.↵
    1. Brown LK

    . Use it or lose it: Medicare's new paradigm for durable medical equipment coverage? Chest 2010;138(4):785–789.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Romero E,
    2. Krakow B,
    3. Haynes P,
    4. Ulibarri V

    . Nocturia and snoring: predictive symptoms for obstructive sleep apnea. Sleep Breath 2010;14(4):337–343.

    OpenUrlCrossRefPubMed
38. 38.
    1. Krakow B,
    2. Ulibarri VA,
    3. Romero EA,
    4. McIver ND

    . A two-year prospective study on the frequency and co-occurrence of insomnia and sleep-disordered breathing symptoms in a primary care population. Sleep Med 2013;14(9):814–823.

    OpenUrlPubMed
39. 39.
    1. Fitzgerald MP,
    2. Mulligan M,
    3. Parthasarathy S

    . Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol 2006;194(5):1399–1403.

    OpenUrlCrossRefPubMed
40. 40.
    1. Bliwise DL,
    2. Friedman L,
    3. Hernandez B,
    4. Zeitzer JM,
    5. Kushida CA,
    6. Yesavage JA

    . Nocturia reported in nightly sleep diaries: common occurrence with significant implications? Health Psychol 2014;33(11):1362–1365.

    OpenUrlPubMed
41. 41.
    1. Krakow B,
    2. Melendrez D,
    3. Ferreira E,
    4. Clark J,
    5. Warner TD,
    6. Sisley B,
    7. Sklar D

    . Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 2001;120(6):1923–1929.

    OpenUrlCrossRefPubMedWeb of Science
42. 42.
    1. Smith S,
    2. Sullivan K,
    3. Hopkins W,
    4. Douglas J

    . Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Sleep Med 2004;5(5):449–456.

    OpenUrlCrossRefPubMedWeb of Science
43. 43.↵
    1. Wickwire EM,
    2. Collop NA

    . Insomnia and sleep-related breathing disorders. Chest 2010;137(6):1449–1463.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    American Academy of Sleep Medicine. The International classification of sleep disorders: diagnostic and coding manual. 2nd edition. Westchester, Illinois: American Academy of Sleep Medicine 2005:51–55.
45. 45.↵
    1. Bastien CH,
    2. Vallières A,
    3. Morin CM

    . Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2(4):297–307.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Johns MW

    . A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14(6):540–545.

    OpenUrlPubMedWeb of Science
47. 47.↵
    1. Berry RB,
    2. Budhiraja R,
    3. Gottlieb DJ,
    4. Gozal D,
    5. Iber C,
    6. Kapur VK,
    7. et al

    . Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events: deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8(5):597–619.

    OpenUrlPubMed
48. 48.↵
    1. Kushida CA,
    2. Littner MR,
    3. Hirshkowitz M,
    4. Morgenthaler TI,
    5. Alessi CA,
    6. Bailey D,
    7. et al

    . Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006;29(3):375–380.

    OpenUrlPubMedWeb of Science
49. 49.↵
    1. Falcone VA,
    2. Damiani MF,
    3. Quaranta VN,
    4. Capozzolo A,
    5. Resta O

    . Polysomnograph chart view by patients: a new educational strategy to improve CPAP adherence in sleep apnea therapy. Respir Care 2014;59(2):193–198.

    OpenUrlAbstract/FREE Full Text
50. 50.↵
    1. Nadeem R,
    2. Rishi MA,
    3. Srinivasan L,
    4. Copur AS,
    5. Naseem J

    . Effect of visualization of raw graphic polysomnography data by sleep apnea patients on adherence to CPAP therapy. Respir Care 2013;58(4):607–613.

    OpenUrlAbstract/FREE Full Text
51. 51.↵
    1. Patel N,
    2. Sam A,
    3. Valentin A,
    4. Quan SF,
    5. Parthasarathy S

    . Refill rates of accessories for positive airway pressure therapy as a surrogate measure of long-term adherence. J Clin Sleep Med 2012;8(2):169–175.

    OpenUrlPubMed
52. 52.↵
    1. Asghari A,
    2. Mohammadi F,
    3. Kamrava SK,
    4. Tavakoli S,
    5. Farhadi M

    . Severity of depression and anxiety in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol 2012;269(12):2549–2553.

    OpenUrlCrossRefPubMed
53. 53.
    1. Babson KA,
    2. Del Re AC,
    3. Bonn-Miller MO,
    4. Woodward SH

    . The comorbidity of sleep apnea and mood, anxiety, and substance use disorders among obese military veterans within the Veterans Health Administration. J Clin Sleep Med 2013;9(12):1253–1258.

    OpenUrlPubMed
54. 54.
    1. Björnsdóttir E,
    2. Benediktsdóttir B,
    3. Pack AI,
    4. Arnardottir ES,
    5. Kuna ST,
    6. Gíslason T,
    7. et al

    . The prevalence of depression among untreated obstructive sleep apnea patients using a standardized psychiatric interview. J Clin Sleep Med 2016;12(1):105–112.

    OpenUrlPubMed
55. 55.
    1. Harris M,
    2. Glozier N,
    3. Ratnavadivel R,
    4. Grunstein RR

    . Obstructive sleep apnea and depression. Sleep Med Rev 2009;13(6):437–444.

    OpenUrlCrossRefPubMedWeb of Science
56. 56.
    1. Lee K,
    2. Baron K,
    3. Soca R,
    4. Attarian H

    . The prevalence and characteristics of REM sleep without atonia (RSWA) in patients taking antidepressants. J Clin Sleep Med 2015 [Epub ahead of print].
57. 57.↵
    1. Sharafkhaneh A,
    2. Giray N,
    3. Richardson P,
    4. Young T,
    5. Hirshkowitz M

    . Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005;28(11):1405–1411.

    OpenUrlPubMedWeb of Science
58. 58.↵
    1. Broström A,
    2. Strömberg A,
    3. Mårtensson J,
    4. Ulander M,
    5. Harder L,
    6. Svanborg E

    . Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. J Sleep Res 2007;16(4):439–447.

    OpenUrlCrossRefPubMedWeb of Science
59. 59.↵
    1. Dunn RL,
    2. Donoghue JM,
    3. Ozminkowski RJ,
    4. Stephenson D,
    5. Hylan TR

    . Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. J Psychopharmacol 1999;13(2):136–143.

    OpenUrlAbstract/FREE Full Text
60. 60.↵
    1. McFadyen TA,
    2. Espie CA,
    3. McArdle N,
    4. Douglas NJ,
    5. Engleman HM

    . Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy. Eur Respir J 2001;18(6):996–1002.

    OpenUrlAbstract/FREE Full Text